Mark Skinner

Mark Skinner is an Adjunct Assistant Professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University. His work focuses on hemophilia care, gene therapy, and patient-reported outcomes.

Research Interests: Skinner's research spans hemophilia treatment accessibility, gene therapy safety, pain management in bleeding disorders, and health equity. He emphasizes patient-centered metrics like the PROBE study and coreHEM initiatives.

Scientific Trends: Recent articles analyze gene therapy adoption barriers, quality of life metrics post-treatment, and standardized outcome sets for hemophilia. These works stress cross-cultural implementation challenges and telemedicine integration during the pandemic.